Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(27 sites)

France

CHU Amiens, Amiens

CHU Angers, Angers

CH Argenteuil, Argenteuil

CHU Bordeaux, Bordeaux

Brest University Hospital, Brest

CHU Caen, Caen

CHU Clermont Ferrand, Clermont-Ferrand

CHU Dijon, Dijon

CH Le Mans, Le Mans

CHU Lille, Lille

CHU de Limoges, Limoges

HCL, Lyon

APHM La Timone, Marseille

CHU Montpellier, Montpellier

CHU Nantes, Nantes

CHU Nice, Nice

APHP Avicennes, Paris

APHP Bichat, Paris

APHP Cochin, Paris

APHP Henri Mondor, Paris

APHP Pitié Salpétrière, Paris

APHP Saint-Louis, Paris

CH Quimper, Quimper

CHU de Reims, Reims

CHU Rennes, Rennes

CHU saint-Etienne, Saint-Etienne

CHU Tours, Tours